'A procurement mindset must not impede equitable access to medicines that offer significant benefits'

“It’s time to reorient the mindset around Pharmaceutical Benefits Scheme reimbursement. Australians with a clear medical need should not miss out on access to an innovative medicine with proven clinical benefit because the patient pool is considered too large to allow for Government funding,” said Eli Lilly general manager Tori Brown. …